MCQOPTIONS
Saved Bookmarks
| 1. |
U.S. regulators have approved whose aducanumab as the first treatment to attack a likely cause of Alzheimer's disease? |
| A. | Amgen Inc |
| B. | Pfizer Inc |
| C. | Biogen Inc |
| D. | Gilead Sciences Inc |
| E. | Vertex Pharmaceuticals Inc |
| Answer» D. Gilead Sciences Inc | |